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Abstract:  
The natural sciences are in the midst of a reproducibility crisis. Scientists don’t replicate 
existing data and when they attempt to do so they often fail. Nevertheless, survey data 
shows that scientists largely trust the non-replicated data they are using. The question of 
why this is so has not been raised in the debate about the reproducibility crisis. Here I 
will claim that one reason for this trust is a hitherto unidentified form of replication, 
which I will call ‘micro-replications’ (MRs). Using a case study from the experimental 
life sciences I will illustrate how MRs depend on a crucial part of the experimental 
sciences that is poorly understood, namely experimental controls. The existence of MRs 
suggests that more replication is taking place in the life sciences than current analyses 
imply.  
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1. Introduction 
It is widely accepted among both scientists and philosophers of science that the 
replication of previous experiments is a key element of the scientific process. 
Experiments are replicated to confirm earlier findings (Collins 1985) and to ensure the 
reliability and/or robustness of experimental output (Soler et al. 2012).  
However, two problems have been raised regarding replication in science: first, 
whilst in theory replication might be crucial, in practice scientists rarely reproduce 
existing data (this phenomenon has already been observed more than 30 years ago by 
Harry Collins (1985)).1 Second, when scientists actually make the effort to replicate 
previous results they are often unable to do so. This has led to talk of a ‘reproducibility 
crisis’ in science (Prinz et al. 2011; Begley and Ellis 2012; Mobley et al. 2013). This 
crisis is thought to not only affect the natural sciences but also fields such as 
psychology (Makel et al. 2012). 
Whilst the lack of reproducible data certainly is an alarming state of affairs, it is at 
the same time fascinating to note that scientists –in particular in the life sciences, on 
which this paper will focus – have been marching on for decades without being fazed by 
                                                      
1 Note that I will use the terms ‘reproduction’ and ‘replication’ interchangeably here 
even though there are debates on potential differences between the two terms (see, e.g., 
(Drummond 2009) or (Casadeval and Fang 2010)). 
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the obvious lack of attempts to replicate data.2 Moreover, not only are scientists 
continuing their experimental work in the absence of reproductions, survey data also 
indicates that they still trust the (non-replicated) data they are using (Baker 2016b). 
This raises a series of fascinating and important questions that are not addressed 
in the current debate on the reproducibility crisis: Where does this basic trust in the 
work of others come from? Is this a case of blind trust and ignorance or is there more to 
it? And if the latter is the case then what is it that makes scientists so confident in non-
replicated data?  
Here I will claim that this trust is built on a type of replication that current 
analyses of the problem have overlooked, namely what I will call ‘micro-replications’ 
(MRs). This type of replication has several key features (which also explain why MRs 
have so far evaded the attention of those involved in the debate). First, MRs are not 
done as experiments whose main goal is to recreate (in some form or other) existing 
results. Rather, they are part and parcel of everyday experimental practice. This goes 
against the current consensus in the scientific community that replications are an add-on 
                                                      
2 Those sounding the alarms in recent years were mainly researchers at industry giants 
who heavily depend on findings from pre-clinical research performed in academia 
(Baker 2016a). Life scientists working at universities have now joined the discussion 
and the question of replication has turned into its own field of investigation with several 
studies under way to establish the extent of the problem (see, e.g., Errington et al. 2014; 
Open Science Collaboration 2015; Nosek and Errington 2017). 
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to regular experimentation (discussed in section 2). Second, MRs rely on elements of 
the experimental process that are not well understood, namely experimental controls. As 
I will show in section 3 using the case study of the in vitro binding assay, controls do 
more than just check for artefacts. I will introduce a distinction between an intra- and an 
inter-experimental role of controls to highlight that controls can also form inter-
experimental links by embodying elements from previous experiments in new 
experimental settings (section 4). As I will show using my case study, these links are 
not only crucial for the researcher to have an interpretable experimental output but they 
also serve as built-in replications (MRs) of earlier findings. 
Identifying these MRs is important as it changes the debate about the 
reproducibility crisis (section 5). The dominant view of replication as an add-on can 
give the appearance that there is hardly any replication happening in the life sciences. 
But once we have a more in-depth understanding of the experimental process and the 
role controls play in it we see that – because of MRs – more (successful) replication is 
taking place in everyday research than is generally assumed. This additional level of 
replication also explains (in part at least) the trust researchers put in existing data.  
 
2. Replications as Add-ons 
Even though there is little consensus in the literature (both within the sciences and 
philosophy of science) on the exact definition of replications there is a clear consensus 
that replications are rarely performed in the sciences (Baker 2016b; Goodman et al. 
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2016). This point has already been made by Harry Collins in the 1980s (Collins 1985) 
and has been corroborated by more recent studies (see, e.g., (Makel et al. 2012)). 
The low amount of actual replication attempts in the experimental sciences is 
baffling if we take into account the widely reported problems with irreproducible data: 
if indeed 50% to 80% of existing data cannot be replicated, as some claim (Begley and 
Ellis 2012; Vasilevsky et al. 2013), then shouldn’t the first priority of any researcher be 
to test all the data she is building on? 
In the debate within the sciences it is usually assumed that replications are not 
performed because there is no reward to be had from doing so: replications are not only 
expensive and time-consuming but they usually also don’t translate into high-impact 
publications (if they can be published at all). A large part of the debate has therefore 
focused on how the incentive structures of science could be changed (see, e.g., Alberts 
et al. 2014; Begley et al. 2015; Begley and Ioannidis 2015; Sarewitz 2016a; 2016b). 
But whilst it is certainly the case that the current incentive structures are highly 
problematic and do not encourage the replication of earlier work, the problem with the 
above explanation is that it cannot make sense of the trust researchers clearly put in 
existing data. Not only are researchers continuing to build on existing data without 
replicating it first, survey data also confirms that they largely trust the data they are 
using (Baker 2016b). This raises the intriguing question of where this trust comes from.  
A key assumption that underlies the whole debate about the reproducibility crisis 
– and which is rarely questioned – is the idea that replications are something that has to 
be done on top of what researchers normally do. Replications are seen as add-ons to 
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regular experimental practice that cost money and time. In this framework, it is little 
surprise that scientists don’t perform replications.  
But what if replications, these creators of trust, come in forms that the current 
analytic frameworks don’t account for? In his book ‘Failure. Why Science is so 
Successful’ the biologist Stuart Firestein makes an interesting observation about the 
replication of positive results in science (Firestein 2015). First, Firestein states that 
scientists are right to refrain from reproducing existing results as this would be a waste 
of time and money. But in a somewhat contradictory twist he then also claims that 
researchers do replicate existing work, namely by building on previous work. As 
Firestein puts it: “[E]xperiments get replicated because people from other labs use the 
published results and the methods in their own experiments” (ibid, p. 151).  
There is a different sense of replication implied (but not explained) here: 
somehow replication is part of everyday science as researchers ‘use’ previous results 
and methods in their own work. The challenge, then, is to explain what such re-use 
looks like. What exactly does it mean to use existing data in an experiment? How 
exactly is existing data incorporated, thus becoming part of the current setup? And how 
is this related to replication and trust? 
To find answers to these questions it will be helpful to compare a case of 
experimental work that builds on previous knowledge with a case where there is no or 
little use of existing data. Such a comparative study will allow us to identify factors that 
are present, or more prominent, when researcher build on previous work. These factors 
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might then give us a better picture of what this form of replication could look like and 
how it might work. 
Interestingly, philosophers of science have identified two types of 
experimentation that differ in the extent to which they build on existing knowledge, 
namely ‘exploratory experimentation’ (EE) and ‘theory-driven experimentation’ (TDE) 
(Steinle 1997).3 In the case of the former there is usually little information available on 
the system or phenomenon of interest and researchers have very little or nothing to 
build their new experiments on. In the case of TDE, there is usually a wealth of 
previous knowledge available that is used to inform the setup, execution and 
interpretation of the experiment.  
These different forms of practice can be of great help to an investigation into 
experimentation and replication: if we have an experimental system that can be used for 
both EE and TDE, an analysis of how it is used in practice should allow us to identify 
how researchers replicate existing results by using them in their own experiments, as 
Firestein suggests. 
In the next section, I will turn to a case study that allows us to do exactly that, 
namely the so-called ‘in vitro binding assay’. This experimental system is widely used 
in the life sciences to study protein-protein interactions and can be used for both EE and 
TDE. The analysis of the different applications of the assay will identify a somewhat 
                                                      
3 On the topic of EE and TDE see also (Burian 1997; Steinle 2002; Franklin 2005; 
Elliott 2007; O’Malley 2007; Burian 2007; Waters 2007; Karaca 2013). 
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surprising element that is crucial for the re-use and hence the replication of existing 
experimental data, namely experimental controls. 
 
3. The in vitro Binding Assay 
Proteins are key players in almost all biological systems as they fulfil a variety of roles, 
such as signal propagation, structural support or the catalysis of chemical reactions. In 
order to fulfil these roles proteins must not only be able to interact with other elements 
of the cell (such as DNA molecules or lipids) but also with each other. The analysis of 
protein-protein interactions is therefore a central part of the research conducted in the 
molecular life sciences.  
To perform interaction studies scientists make use of the fact that proteins can be 
extracted from cells, either in a purified form or as part of a whole-cell extract (i.e. an 
extract of all the soluble proteins of a particular cell type). These isolated proteins or 
protein mixtures can then be used to study protein-protein interactions in vitro. One of 
the key assays used for this purpose is the so-called in vitro binding assay. 
 
3.1. The General Setup of the in vitro Binding Assay  
The basic idea behind the in vitro protein binding assay is relatively simple: a protein of 
interest is isolated from its original cellular context and incubated in a test tube with 
another protein (or a mixture of proteins) in a suitable buffer solution. This incubation 
period (usually in the range of one to several hours) allows for the formation of protein-
protein complexes. After incubation, the protein of interest is retrieved from the reaction 
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mixture using a specific retrieval system (see next paragraph). If any of the other 
proteins present in the reaction mixture are able to bind to the protein of interest they 
will be co-retrieved with the protein of interest and can subsequently be identified. 
A modified version of the protein of interest has to be used in this assay in order 
to be able to retrieve it from the reaction mixture. The modification usually consists of 
what is referred to as a ‘tag’, often a short polypeptide that is fused to one end of the 
protein of interest. The tag has a specific binding target (either a small molecule or 
another polypeptide), which can be chemically coupled to synthetic microbeads. The 
modification of the beads with a target and of the protein of interest with a tag provides 
the researcher with a powerful and specific retrieval system: adding the modified beads 
to the reaction mixture will result in the recruitment of the tagged protein of interest 
(and everything that is bound to it). The beads can then be separated from the reaction 
mixture by centrifugation and, following a washing step, all proteins bound to them can 
be eluted using high salt or denaturing conditions (which interrupt regular protein-
protein interactions). These eluted proteins can then be analysed by gel electrophoresis4 
coupled to Western blot analysis or mass spectrometry, two of the main methods used 
in molecular biology to identify specific proteins.  
 
                                                      
4 Gel electrophoresis allows to separate proteins according to their size. Proteins of 
different size will appear on the gel as distinct bands. 
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3.2. Using the in vitro Binding Assay for Exploratory Purposes: Mapping Protein 
Interactions 
A key application of the in vitro binding assay is to map the interaction space of a 
protein X. Such mapping usually represents a form of exploratory research, in particular 
if there is no data available on the interaction partners of X and if there are no known 
binding domains or signal peptides present in X. In such a case the researcher is 
unlikely to have a clear idea about the possible intracellular interactions X might engage 
in. An in vitro binding assay using tagged X and a cell extract can be used to screen for 
potential interaction partners of X.  
The exploratory use of the in vitro binding assay has several characteristic 
features. The readout of the mapping experiment will, for instance, consist of a general 
detection of proteins of all sizes using gel electrophoresis and/or mass spectrometry as 
the point of the experiment is to explore the whole space of possible protein-protein 
interactions for factor X. There is therefore no restriction on what proteins the 
researchers are looking for. 
The openness of the mapping experiment is also reflected in the variation of 
parameters that the researchers are likely to make use of. They might, for instance, use a 
range of different cell extracts derived from different cell types or organisms to explore 
a protein space that is as large as possible. Other parameters that the researchers might 
alter are the salt concentration or the pH of the buffer(s) used (as these parameters can 
directly affect the ability of proteins to interact with each other) or also the duration of 
the incubation period. 
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This variation of parameters and the openness of the readout are needed because 
the exploratory in vitro binding assay does not build in any strong way on existing data; 
there simply is very little specific information that could inform the setup, execution or 
interpretation of this exploratory assay.  
 
3.3. Using the in vitro Binding Assay for Guided Experimentation 
Besides the exploratory setup the in vitro binding assay can also be used to test 
hypotheses about the interaction between two particular proteins. This is a case of 
guided experimentation, meaning it builds directly on existing data (which formed the 
basis for the hypothesis being tested). 
To illustrate this application of the assay I will use the following example: assume 
a) that researchers have previously identified two proteins X and Y which form a stable 
complex and b) that X contains a signal peptide known to mediate binding to proteins of 
class ‘Z’. Further assume c) that Y is a member of Z. The presence of the signal peptide 
in X would imply that X and Y can interact directly with each other (hypothesis 1) and 
that this interaction is mediated by the signal peptide (hypothesis 2). Both of these 
hypotheses could be tested using the in vitro binding assay. 
To test hypothesis 1, the researcher would isolate both X and Y and use them in a 
binding assay (with either of them modified with a tag) to check whether retrieving one 
protein from the reaction mixture will co-retrieve the other. As both proteins have been 
isolated from their cellular context the researcher can assume that there are no other 
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proteins present in the reaction mixture. Therefore, if an interaction is observed it can be 
concluded that the interaction is direct and not mediated by another factor. 
To test hypothesis 2, the researcher would not only have to test the direct 
interaction between X and Y but also check for an interaction between the two proteins 
in the absence of a functional signal peptide in X. One way to create such a context 
would be to remove the signal peptide altogether, for instance by creating a mutant of X 
that lacks the signal peptide. If this mutant form of X does not show any binding to Y 
whilst the full-length version of X does, hypothesis 2 would be supported.  
In contrast to the exploratory use of the assay the readout of the guided 
experiment would focus exclusively on the specific detection X and Y, as it is only 
these two factors the researcher is interested in. This also means that the researchers are 
unlikely to engage in an extensive variation of experimental parameters as they know 
what they are looking for (and how to look for it). They would simply use the settings 
that have worked before when X and Y were found to form a stable complex. All these 
different features are in line with what Steinle describes as guided experimentation or 
TDE (Steinle 1997). 
 
3.4. Artefacts and Controls 
An important issue that affects both the exploratory and guided uses of the in vitro 
binding assay is the possibility of artefacts. This is a crucial issue as artefacts negatively 
affect the trust a researcher can put in the results obtained.  
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A key factor in this context is that proteins can, in principle at least, interact with a 
great range of surfaces. Depending on parameters such as pH, temperature, and salt 
concentration the protein will display particular features on its surface (such as charged 
or hydrophobic patches). These features will allow the protein to interact with any 
matching surface, including that of synthetic beads.  
This is a problem as everything that is bound to the beads after the retrieval and 
washing steps will be defined as a potential interaction partner of the protein of interest. 
The researcher therefore needs to be able to identify such unspecific binding events 
(often referred to as ‘background binding’). If there is no system in place to do so the 
researcher will not be able to judge whether the marks on the gel represent true binding 
events or whether the experimental system is misfiring, i.e. producing false positives. 
To exclude such artefacts the researcher will therefore usually include a negative 
control in the experiment.  
 
3.4.1. The Negative Control 
In an in vitro binding assay there are three potential sources of background binding: 1) 
the surface of the beads, 2) the target with which the beads are modified, and 3) the tag 
that is fused to the protein of interest. The proteins present in the reaction mixture could 
bind to any of these sites. 
To control for all three sources of background binding the researcher will prepare 
a separate sample that a) consists of beads that are b) modified with a target and c) pre-
loaded with the tag that was used to modify the protein of interest. The only difference 
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between this sample and the others used in the assay is the absence of protein X (as only 
an empty tag is used). This control can be used to exclude background binding as any 
signal that appears in this sample cannot be due to the presence of X. Any signal that is 
equally strong in the negative control and the actual sample will therefore be classified 
as a false positive. If the signal appears in both the negative control and the sample 
containing X but is stronger in the latter this indicates that there could be a real 
interaction taking place (as the signal is above background binding). This illustrates 
another important role controls can play, namely as calibration devices that set the 
baseline signal of the retrieval system (Grinnell 1992). 
 
3.4.2. The Positive Control 
Performing an in vitro binding assay means to manipulate the protein of interest (as it 
has to be modified, isolated and then immobilised on the beads). All of these 
interventions risk deactivating the protein of interest, as changes in salt concentration, 
pH or temperature can lead to the unfolding or lysis (disintegration) of its polypeptide 
chain. If this happens the basic setup of the assay becomes faulty and it might no longer 
be able to produce positive results. If this fault is not detected the system could produce 
false negative results.  
To exclude such false negatives the researcher will include a positive control 
which verifies that the protein of interest is active under the conditions chosen (Baker 
and Dunbar 2000). The positive control will usually contain a known binding partner of 
the protein of interest that is tested in parallel to the other samples of the binding assay. 
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By including this control the researcher will be able to interpret negative results: if the 
positive control shows an interaction with factor X but all the other samples don’t show 
any interaction, the researcher knows that she is dealing with a true negative result. If 
the positive control does not show any signal she knows that factor X has become 
inactivated at some point and that negative results might be an artefact.5  
As in the case of negative controls, the positive control has to do with the 
interpretation of the marks obtained in the experiment: if the positive control is missing 
or not working the researcher cannot exclude that negative results are due to the 
inactivity of the protein of interest, meaning she will not be able to obtain an 
interpretable readout. 
The positive control can also be used as a calibration device. If, for instance, 
different mutants of an enzyme are tested for activity (and if it is known that the full-
length protein is active), then the signal provided by the full-length sample can serve as 
a measuring stick for the other samples and give the researcher an idea of the signal 
strength that can potentially be reached under the conditions used (Grinnell 1992). 
 
In summary, we see that both the negative and positive controls 1) serve as calibration 
devices and 2) can be used to exclude artefacts. Controls allow the researcher to put 
                                                      
5 Note that in this case the researcher will also perform a positive control on the positive 
control to make sure it is not the source of the problem. Controls ultimately only work 
as part of a complex network, a point I will return to in section 4. 
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trust in the system they are using, the manipulations they are performing and the results 
they obtain. Because of this they help to obtain a meaningful, i.e. interpretable output of 
the experiment. Without controls the researcher cannot read the marks she obtains. 
 
3.5. The Intra-Experimental Role of Controls 
In section 3.4.1 we have seen how the negative control is used to separate the bands that 
appear on a gel into meaningful sets: by having a negative control that was performed in 
parallel to the other samples (and which is analysed as part of the same gel) the 
researcher is able to partition the bands visible on the gel into two classes  (‘potential 
interactors’ and ‘background binding’).  
This means that an initial interpretation of the raw data provided on the gel (all the 
bands that appear) is done in situ when looking at the gel, comparing the different lanes 
with each other. Crucially, the controls serve as an ‘other’, i.e. as a difference maker 
(not in a causal but a semiotic sense); only by including a negative control is it possible 
for the researcher to create sets of marks that can be compared in a fruitful manner, i.e. 
to have a meaningful readout for the experiment. Its presence creates the context in 
which researchers can talk about facts and artefacts. 
This particular use of the negative control is an example of what I will refer to as 
the intra-experimental mode in which controls can function: by creating a crucial 
difference between the samples of the same experiment the use of a negative control 
opens up a space in which meaningful output can be created. This space is created 
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through the juxtaposition of two samples that have been processed in parallel and which 
are present on the same output (a gel in this case).6 
A positive control can play a similar intra-experimental role as it is again the 
differential space it creates within the same experiment that is important for its function. 
A sample in which no bands become visible (for instance in the above-described assay 
that looks at the interaction between X and Y) can be compared to the positive control 
(which, if it works, confirms that both X and Y are active under the conditions chosen). 
This comparison between the marks obtained for each sample confirms that all the 
factors involved are in principle active and allow the researcher to make a reliable 
statement about the interaction (or absence of interaction) between X and Y. 
This intra-experimental use of controls, which can be part of both guided and 
unguided experiments, corresponds to the more traditional role of controls, i.e. their 
function to check for artefacts. However, as I will explain in the next section, the 
examples discussed here allow us to identify an additional mode in which controls can 
function, which I will refer to as the inter-experimental role of controls. This mode, I 
                                                      
6 If the controls were loaded and analysed on different gels the comparison that is 
essential to the use of controls would no longer work. If, for instance, there were 
differences in the intensity of the signals obtained the researcher could not exclude that 
the two gels display a different staining behaviour, which could mean that one shows a 
weaker signal than the other even though the same amount of protein is present.  
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claim, is a crucial part of what makes controls tools for establishing trust when building 
on the work of others. 
 
4. Building on Previous Work 
The two setups of the in vitro binding assay described in section 3 are ideal in the sense 
that the assay, as used in daily practice, will contain adjustments to account for 
particularities of the proteins of interest or the specific question that is being addressed. 
Nevertheless, the examples help to illustrate some of the key elements that are required 
to make use of the assay for both guided and unguided uses. Interestingly, even though 
basic positive and negative controls are used in both cases, there are crucial differences 
in how the controls are employed in each case. These differences come to the fore when 
we look at the inter-experimental use of controls. 
 
4.1. The Inter-Experimental Role of Controls 
The above description of the guided experiment has highlighted several ways in which 
the researchers might make use of existing knowledge about the entities and processes 
analysed. They already know, for instance, the sequence and the behaviour of the signal 
peptide in X (‘The type of signal peptide present in X mediates the interaction with 
proteins of class Z’). They also have information about the behaviour of X and Y as 
they know that these two proteins form a stable complex with each other (see the 
starting assumptions made in section 3.3). It is this and other previously established 
knowledge that lead to the formulation of the two hypotheses that are tested, namely 
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that proteins X and Y interact directly and that they do so via the signal peptide present 
in X.  
This knowledge is the result of specific experiments and sequence analyses that 
have gone before: the sequence of the signal peptide will have been defined using 
functional assays performed with one or several other proteins containing that specific 
peptide. In the course of such experiments it will also have turned out that the peptide 
mediates the direct interaction with proteins of class Z. This knowledge is therefore the 
outcome of particular experiments that have been performed earlier and/or elsewhere 
using the same class of proteins that is also used in the current experiment. This 
knowledge not only guides the questions being asked but also informs the setup and the 
execution of the assay.  
This can also be seen in the way controls are being used. If we compare the 
positive controls used in the guided and unguided experiments described in section 3 we 
discover interesting differences. For instance, if a positive control is used at all in the 
unguided case it will be a random protein, in the sense that any protein that is known to 
interact with X can be used to verify that X is active. This also means that the 
experimental conditions used for the positive control (e.g. pH, salt concentration, etc.) 
are not necessarily binding for the actual exploration performed – other proteins might 
require very different conditions in order to interact with protein X and the researcher 
might therefore use a range of salt concentrations and different pH values.  
The guided experiment, however, is building on specific experimental findings 
and specific events happening between two known factors. The controls used therefore 
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have to be specific as well: the point is not simply to show that factors X and Y are 
active but that they are capable of undergoing the activities that have been ascribed to 
them in earlier experiments. Factor X, for instance, has to be able to bind to proteins of 
class Z (to which factor Y belongs). The aim is to show that the signal peptide in X is 
accessible and hence functional, as it was found to be in past experiments. To show this 
the researcher will have to reproduce this past event (the same has to be done for Y, i.e. 
it has to be shown that Y can, in principle at least, bind to signal peptide-containing 
proteins). 
In the guided experiment the positive controls will therefore consist of a specific 
protein belonging to class Z (controlling for the activity of X) and a protein that 
contains a signal peptide (controlling for the activity of Y). Specific positive controls 
are used because it is a particular type of event that needs to be verified in order for the 
researcher to trust the output of the experiment. This also means that the experimental 
conditions used will have to be the same as those used for the positive control (and by 
extension that of the previous experiments), since the positive control is of the same 
class as the proteins analysed and all samples have to be directly comparable.  
The controls therefore create a close link with previous experiments, meaning 
they establish a continuity between the experiment at hand and the earlier work on 
which it builds. With this continuity also come expectations, experimental conditions 
and trust. So in addition to the intra-experimental role described above there is also an 
inter-experimental role controls can play, at least in the experimental life sciences. 
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4.3. Creating Trust through Experimentation 
The inter-experimental mode of controls is significant in the context of this paper 
because it entails the replication of earlier results. Particular previous experiments are 
brought into the experiment at hand through the inter-experimental controls used. The 
previous results are re-produced in control samples and are part of what makes the data 
of the current experiment readable and trustworthy. Only if such a local network with 
guiding and interpretative power is established do researchers have a well-defined 
experimental outcome to work with.  
We start to see here, then, a possible interpretation of the statement Firestein 
made, namely that scientists reproduce earlier experiments by using them in their own 
experiments. Replications of earlier results happen as part of regular experiments and 
not just in what is explicitly designed and labelled as a replication of earlier results. 
These replications-via-controls don’t attempt to repeat a whole study or figure from 
earlier work. They rather pick one aspect that is crucial in guiding the experiment at 
hand and make it part of the current setup to establish readability and trustworthiness 
(the two being intertwined). Because of their small-scale character I will refer to these 
replications as ‘micro-replications’ (MRs).  
Importantly, scientists not only use MRs as part of their regular experimentation 
but they are also able to read them when they encounter work by others. They know 
when controls are missing and this will often make them question the data they are 
presented with. Scientists are likely to ignore data that is poorly controlled or to set out 
to repeat it in their own laboratory to see for themselves. 
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Identifying MRs is not only important for practising scientists but also for those 
analysing the reproducibility crisis. A lot has been made of recent claims that up to 80% 
of existing data cannot be reproduced. However, not only are these claims based on 
small-scale studies (a problem current projects in meta-science aim to address, see 
footnote 2) but they are also based on a particular picture of what replications are and 
how they work.  
Once we realize that (micro-)replications happen as part of normal 
experimentation, the picture starts to change. What the analysis provided here suggests 
is that scientists do more (successful) replications than current analyses are able to 
identify. Because of the controls they use scientists not only put trust in the output of 
their own experiments but they also build trust in the data published by others. The 
presence of MRs explains (in part at least) why researchers have been so confident in 
pushing ahead without setting up replication experiments, as defined by existing 
accounts. 
 
5. Conclusions: Trust and the Dark Matter of the Experimental Sciences 
There are (at least) two questions the reproducibility crisis raises: 1) Why is so much 
data irreproducible? and 2) why do scientists not make more replications of previous 
data? These two questions lead to further questions such as 3) how could reproducibility 
be increased. 
The greater part of the literature on replication in science focuses on questions 1) 
and 3). Hardly anyone asks why scientists are not more pro-active, constantly checking 
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previous results. Part of the reason no one asks question 2) is because it is usually 
assumed that we already have the answer (scientists don’t want to/can’t afford to invest 
the time and money needed for replications because there are no benefits to be had from 
doing so). But this answer is unsatisfactory in light of the trust researchers clearly put in 
the data they are using.  
Here I have claimed that this trust is – in part at least – based on a form of 
replication that has so far not been picked up by commentators on the issue, namely 
what I have called ‘micro-replications’ (MRs). This form of replication is part of 
everyday research, as it is built into normal experimentation through the inter-
experimental use of controls. This suggests that the extent of the reproducibility crisis – 
at least in the experimental life sciences – might be less dramatic than some of the 
ongoing discussions imply, as crucial forms of replications are overlooked due to a 
flawed conceptual framework within which the analysis of the crisis is taking place. 
An interesting question the analysis provided here raises is why MRs have evaded 
our attention for so long. A key reason for the invisibility of MRs, I think, is the fact 
that they depend on a part of the experimental process that is still poorly understood, 
namely the experimental controls. The invisibility of controls might be explained by the 
fact that their use is not something that is discussed in review articles, original research 
articles or textbooks. How to use a control and what controls to use are questions that 
come up in the Q&A section of talks or in informal laboratory meetings, making it an 
element of scientific practice that can be difficult to track for philosophers and 
historians of science. Controls are also crucial elements of the peer review process, 
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another element of science that is largely hidden from sight and difficult to access and 
assess (asking for different/additional controls is probably one of the key parts of the 
review process in the experimental sciences). Controls therefore represent something 
like the dark matter of experimentation, at least from the viewpoint of philosophy: they 
are a central part of what holds the (experimental) universe together but they are almost 
invisible to the researcher who is trying to understand that universe. 
But despite these challenges, if controls indeed have the importance for the 
progress and the reliability of the experimental sciences that I propose here then it will 
be crucial for philosophers and historians of science to develop a more detailed 
understanding of how they shape the research process and the thinking of researchers. If 
we do so we will also be in a better position to develop an understanding of more 
general issues, such as the reproducibility crisis in science.  
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